What's breaking now, across thousands of outlets.
Daniel Chojnowski, JHHP’s current CFO, will provide stability so that the Baltimore-area insurer can recruit full-time for its next chief executive, the company said.
We haven't written up this one. Healthcare Dive has the full story — the link below goes straight to it.
It offers a "safe way to target chemo resistant tumors," the study's author Ozgur Sahin told Newsweek.
Analysts warn a disruption in Chinese sources of common antibiotics or blood thinners could leave American patients with no reliable alternative.
More than six years after the pandemic arrived and ivermectin and hydroxychloroquine were first touted as COVID cures, the evidence shows more than ever that they don't work.
Marlboro-maker Altria is seeking to force the FDA to overhaul a review process it says has blocked newer nicotine products from reaching the market.
Ahead of respiratory illness season, professional organizations have issued guidance on flu, Covid, and RSV vaccines.
Instead of preparing to settle into my new life as a retiree, I unexpectedly took on another full-time job: trying to stay alive.
